Agenda
Participant registration
Opening by MC
Singing Indonesia national anthem
Welcoming speech and opening ceremony
Dr.dr.Kartika Widayati,Sp.PD,Subsp.HOM (K)
Building up multidisciplinary cancer care: global standards, local determination, and institutional role
Chair: Prof.Dr.dr.Ibnu Purwanto,Sp.PD, Subsp.HOM (K)
Multidisciplinary approach in cancer management: global standards
Prof. Rolf A. Stahel, MD
(ESMO President 2014-2015, University Hospital of Zürich, Switzerland)
Multidisciplinary approach in cancer management: Yogyakarta experience
Prof.dr.Susanna H. Hutajulu, Ph.D, Sp.PD, Subsp.HOM (K)
Institutional role: initiation and strenghtening of multidisiciplinary cancer management
Director of RSUP dr.Sardjito
Institutional role: advancing education, collaboration, and institutional excellence
Dean of Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada
Discussion
Photo session
Navigating diagnostic complexity and applying therapeutic innovation in lung cancer
Chair: Dr.dr.Djumhana,Sp.PD, Subsp.HOM (K)
Co chair: dr.Mardiah Suci Hardianti, Ph.D, Sp.PD, Subsp.HOM Subsp.HOM (K)
Lung cancer: Navigating diagnostic complexity and applying therapeutic innovation
Prof. Solange Peters, MD, Ph.D
(President of International Cancer Foundation, ESMO Past President 2020-2022)
Discussion
Coffee break (served)
Multidisciplinary care models for patients with early to advanced NSCLC
Chair: Prof.dr.Susanna Hilda Hutajulu, Ph.D, Sp.PD, Subsp.HOM (K)
Co.Chair: dr.Nur Rahmi Ananda,Sp.PD-KP
Perioperative treatment strategies in NSCLC: A surgeon’s perspective
dr. Achmad Faisal, Sp. B.T.K.V, Subsp. T. (K)
Targeting immune response across lung cancer propagation: from early to advance disease
Prof. Solange Peters, MD, Ph.D
(President of International Cancer Foundation, ESMO Past President 2020-2022)
Case presentation
Case presenter: Dr.dr.Kartika Widayati,Sp.PD, Subsp.HOM (K)
Panel discussion
Addressing unmet needs with emerging later-line strategies in metastatic colorectal cancer
Chair: Prof. Dr. dr. Abdul Muthalib, Sp.PD-KHOM
Co.Chair: Dr. dr. A. Yuda Handaya, Sp.B,KBD
Surgical strategies for colorectal cancer with synchronous metastases
Vicente Pla Marti,MD,Ph.D.
(Dept.of Digestive Surgery, Universidad de Valencia, Spain)
Discussion
Evolving strategies for later line systemic treatment in mCRC
dr. Johan Kurnianda, SpPD, Subsp.HOM (K)
Case sharing: Unmet needs, clinical challenges and options of strategies in metastatic colorectal cancer management
Dr. dr. Andhika Rachman,Sp.PD, Subsp.HOM (K)
Discussion
Prayer Break
Evolution of HER2 and hormone-receptor positive breast cancer treatment paradigm
Chair: Prof. Dr. dr. Abdul Muthalib Sp.PD-KHOM
New heights in the paradigm of HR+ metastatic breast cancer management
dr. Trinugroho Heri Fadjari, Sp.PD, Subsp.HOM (K)
Targeting HER2-low and HER2-ultralow in chemotherapy naive HR+ HER2 negative advance breast cancer
Dr. dr. Eko Adhi Pangarsa, Sp.PD, Subsp.HOM (K)
Discussion
Enhancing survival outcomes of NSCLC patients: from clinical evidence to clinical excellence
Chair: dr. Dian Pratiwi Sp.PD, Subsp. HOM (K)
Lung cancer diagnosis in the precision oncology era: navigating clinical and procedural challenges
dr. Thomas Handoyo, SpPD-KPMK, FINASIM (TBC)
Targeted treatments in early to advance NSCLC
Prof. Rolf A. Stahel, MD
(ESMO President 2014-2015, University Hospital of Zürich, Switzerland)
Case sharing and discussion in metastatic lung cancer
Dr. dr. Wulyo Rajabto, Sp.PD, Subsp. HOM (K)
Discussion
Optimizing oral chemotherapy strategies in mCRC the across continuum care
Chair: Prof. Dr. dr Ibnu Purwanto, Sp.PD, Subsp. HOM (K)
The role of oral Fluoropyrimidines in mCRC therapy
Dr. dr. Jeffry Beta Tenggara Sp.PD, Subsp. HOM (K)
Later-line Fluoropyrimide-based therapy in mCRC: Evidence and clinical practice insights
Prof. Dr. Dr. dr. Ikhwan Rinaldi Sp.PD, Subsp. HOM (K), S.H., M.Epid, M.P.Ked, FACP, FINASIM, FisQua
Discussion
Booth-side refreshment
Dinner Meeting Session
Chair: dr.Johan Kurnianda, Sp.PD, Subsp.HOM (K)
Dinner meeting opening
Dean of Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada
Personalized surgery for breast cancer
Prof. Dr. med. Peter C. Dubsky
Switzerland (ONLINE)
Navigating the treatment of breast cancer brain metastases across the HER2 spectrum
Adjunct Associate Professor Andrea Wong, MBChB (Hons), MRCP, MMed (Int Med)
(Department of Haematology-Oncology, National University Cancer Institute, Singapore)
Discussion
Remarks from ICF
Remarks from Perhompedin Jogja
Closing by MC
Participant registration
Event Opening by MC
Guest lecture opening
Dean of Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada
Guest Lecture
Chair: Prof.dr. Susanna Hilda Hutajulu, Ph.D, Sp.PD, Subsp.HOM (K)
Understanding triple negative breast cancer heterogeneity: from molecular subtyping to precision therapeutics
Adjunct Associate Professor Andrea Wong, MBChB (Hons), MRCP, MMed (Int Med) (TBC)
(Department of Hematology-Oncology, National University Cancer Institute, Singapore)
Discussion
Current challenges and surfacing trend in the treatment of ALK-rearranged lung cancer
Chair: dr. Johan Kurnianda, Sp.PD, Subsp.HOM (K)
Advances and diagnostic challenges in lung cancer pathology
dr. Didik Setyo Heriyanto Ph.D., Sp.PA., Subsp.D.H.B.(K), Subsp.Kv.R.M.(K)
Treatment strategies accross lines of treatment for ALK-rearranged NSCLC
Prof. Solange Peters, MD, Ph.D
(President of International Cancer Foundation, ESMO Past President 2020-2022)
ALK-Targeted Therapy in Clinical Practice: Learning Through Cases
dr.Daniel Rizky, Sp.PD, Subsp.HOM (K)
Discussion
Coffee Break
Transforming Breast Cancer Care Across the Disease Continuum
Chair: dr.Damai Santosa,Sp.PD, Subsp.HOM (K)
Management of HR+/HER2- disease: latest practices, unanswered questions, and future direction
Clin Asst Prof Tan Jing Ying Tira BSc, MBBS, MRCP
(National Cancer Centre Singapore)
Hormone receptor positive breast cancer management: treatment strategies in resource limited settings and local experience
Dr. dr. Kartika Widayati, Sp.PD., Subsp.HOM(K)
Non surgical treatment for operable breast cancer: emerging controversy
Prof. Dr. med. Peter C. Dubsky, Switzerland (ONLINE)
Discussion
Advancing precision in hematology oncology: from molecular insights to real world practice
Chair: dr. Agus Fitriyanto Achmad, Sp.PD, Subsp.HOM (K)
Multiple myeloma: The state-of-the-art management across disease continuum
dr. Mardiah Suci Hardianti, Ph.D., Sp.PD., Subsp. HOM (K)
Anti-CD38 monoclonal antibodies in multiple myeloma: transforming the treatment landscape
Dr.dr.Budi Setiawan, Sp.PD., Subsp. HOM(K)
Discussion
Optimizing Tyrosine Kinase Inhibitor therapy in chronic myeloid leukemia
Chair: dr. Agus Fitriyanto Achmad, Sp.PD, Subsp.HOM (K)
Optimizing Tyrosine Kinase Inhibitor therapy in chronic myeloid leukemia
dr. Siswi Oktarini Sp.PD., Subsp. HOM(K)
Discussion
Hepatocellular carcinoma: advances in diagnosis and emerging therapeutic strategies
Chair: TBC
Optimizing the diagnosis of hepatocellular carcinoma: current challenges and best practices
dr. Catharina Triwikatmani, M. Kes., Sp.PD., Subsp. G.E.H. (K)
Cellular therapy in hepatocellular carcinoma: current evidence and future perspectives
Prof. Dr. dr. Aru Wisaksono Sudoyo, Sp.PD, Subsp.HOM(K)
Case presentation CIK in HCC (dr. Noviantoro Sunarko, Sp.PD) and Discussion
Advances in systemic therapy and supportive care: optimizing patient outcomes
Chair: dr. Kun Salimah, M.Biomed, Sp.PD, Subsp.HOM(K)
The Evolving Role of Immunotherapy in Advanced Renal Cell Carcinoma
dr. Yasjudan Rastrama Putra, Sp.PD, Subsp. HOM (K)
Personalized antiemetic approaches: quality of life outcomes in CINV control
dr. Dian Pratiwi Sp.PD, Subsp. HOM (K)
Discussion
Breast cancer MDT: Precision treatment through a teamwork
Chair: dr. Mardiah Suci Hardianti, Ph.D, SpPD, Subsp.HOM (K)
Opening by MC
Evolving surgical approach in breast cancer
dr. Sumadi Lukman Anwar, M.Sc, Ph.D, Sp.B, Subsp.Onk. (K)
Management of early HER2-positive breast cancer: from neoadjuvant therapy to individualized treatment
Dr. dr. Agus Jati Sunggoro, Sp.PD, Subsp.HOM (K)
Treatment landscape in cases with advanced HER2 positive breast cancer
Prof Tan Jing Ying Tira BSc, MBBS, MRCP
Optimizing local control in early to advanced breast cancer
dr. Henry Kodrat, Sp.Onk.Rad., Subsp. KLSSP, (K)., M.Pd.Ked
Case presentation
(dr.Mardiah Suci Hardianti,Ph.D,Sp.PD, Subsp.HOM (K)) and
Panel Case Discussion
Colorectal cancer MDT: Improving outcomes with a personalized care
Chair: dr. Yasjudan Rastrama Putra, Sp.PD, Subsp. HOM (K)
Co.Chair: dr. Bestari Ariningrum Setyawati, M.Si.Med, Sp.Rad
Opening by MC
Surgical strategies for colorectal cancer with synchronous metastases
Vicente Pla Marti,MD,Ph.D.
(Dept.of Digestive Surgery, Universidad de Valencia, Spain)
Understanding Colorectal Cancer Pathology: Diagnostic, Prognostic, and Predictive Biomarkers
(TBC)
Radiotherapy in colorectal cancer
dr.Lidya Meidania,Sp.Onk.Rad(K)
Case presentation
(dr.Yasjudan Rastrama Putra,Sp.PD, Subsp.HOM (K)) and
Panel Case Discussion
all chairs and speakers
Prayer Break/Special Symposium Preparation
Leadership in Cancer Care- A Journey of Commitment, Science, Collaboration, and Advocacy
Chair: Prof. Dr. dr. Aru Wisaksono Sudoyo, Sp.PD, Subsp. HOM (K)
Opening by MC
Leadership in Cancer Care- A Journey of Commitment, Science, Collaboration, and Advocacy
Prof. Rolf A. Stahel, MD
(ESMO President 2014-2015, University Hospital of Zürich, Switzerland)
Discussion
Doctorpreneur
Chair: Salsabila Mutia Rahmadani, S.I.Kom
Financial freedom for doctors
dr.Dandung Bawono,M.Sc,Sp.A, CFP
Becoming medical influencer vs expert provider
dr.Gia Pratama
Discussion
Poster and doorprize winner announcement
Closing
